Drug Side Effects
Search
OLFACTORY DYSFUNCTION
OLFACTORY DYSFUNCTION
was reported 42 times
These drug classes are most commonly taken by patients reporting OLFACTORY DYSFUNCTION:
#
Drug
Count
0
5-alpha Reductase Inhibitor [EPC]
8
1
Platinum-based Drug [EPC]
4
2
Atypical Antipsychotic [EPC]
3
3
CD20-directed Cytolytic Antibody [EPC]
3
4
Interleukin-4 Receptor alpha Antagonist [EPC]
3
5
Microtubule Inhibitor [EPC]
3
6
Programmed Death Ligand-1 Blocker [EPC]
3
7
CTLA-4-directed Blocking Antibody [EPC]
2
8
GLP-1 Receptor Agonist [EPC]
2
9
Kinase Inhibitor [EPC]
2
10
Nucleoside Metabolic Inhibitor [EPC]
2
11
Prostacyclin Receptor Agonist [EPC]
2
12
Soluble Guanylate Cyclase Stimulator [EPC]
2
13
Aldosterone Antagonist [EPC]
1
14
Alkylating Drug [EPC]
1
15
Angiotensin 2 Receptor Blocker [EPC]
1
16
Anti-epileptic Agent [EPC]
1
17
BCL-2 Inhibitor [EPC]
1
18
Benzodiazepine [EPC]
1
19
Calcium Channel Blocker [EPC]
1
20
Cholinergic Muscarinic Antagonist [EPC]
1
21
Corticosteroid [EPC]
1
22
Dihydropyridine Calcium Channel Blocker [EPC]
1
23
Erythropoiesis-stimulating Agent [EPC]
1
24
Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]
1
25
Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC]
1
26
Leukotriene Receptor Antagonist [EPC]
1
27
Macrolide Antimicrobial [EPC]
1
28
Melanocortin 4 Receptor Agonist [EPC]
1
29
Mood Stabilizer [EPC]
1
30
Noncompetitive AMPA Glutamate Receptor Antagonist [EPC]
1
31
Nonsteroidal Anti-inflammatory Drug [EPC]
1
32
Orexin Receptor Antagonist [EPC]
1
33
P2Y12 Platelet Inhibitor [EPC]
1
34
Phosphodiesterase 5 Inhibitor [EPC]
1
35
Programmed Death Receptor-1 Blocking Antibody [EPC]
1
36
Proton Pump Inhibitor [EPC]
1
37
Purine Antimetabolite [EPC]
1
38
RNA Synthetase Inhibitor Antibacterial [EPC]
1
39
Serotonin-3 Receptor Antagonist [EPC]
1
40
Sodium-Glucose Cotransporter 2 Inhibitor [EPC]
1
41
Thalidomide Analog [EPC]
1
42
Tyrosine Kinase 2 Inhibitor [EPC]
1
43
Vasopressin V2 Receptor Antagonist [EPC]
1
44
Xanthine Oxidase Inhibitor [EPC]
1